Sulidapa SM 10/100/1000 Tablet ER
Marketer
Aareen Healthcare Pvt Ltd
Salt Composition
Dapagliflozin (10mg) + Metformin (1000mg) + Sitagliptin (100mg)
Overview Sulidapa SM 10/100/1000 Tablet ER
Diabetease Control XR 10/100/1000 is a multi-component medication designed to manage blood glucose. It complements diet and exercise to enhance glycemic control in adult patients with type 2 diabetes. This medication facilitates efficient insulin use, resulting in reduced blood sugar. Diabetease Control XR 10/100/1000 may be administered with or without food, but consistent daily timing is recommended. Dosage is determined by your physician; discontinuation without medical consultation may lead to elevated blood sugar and increased risk of severe complications such as renal impairment and vision loss. This medication is one component of a comprehensive treatment plan encompassing a balanced diet, regular physical activity, and weight management as directed by your doctor. Common adverse effects include urinary tract infections, nasal congestion, pharyngitis, and upper respiratory infections. Adequate hydration helps mitigate dehydration. Genital fungal infections are a potential side effect; good hygiene practices are advisable. Prior to commencing Diabetease Control XR 10/100/1000, disclose any kidney or liver dysfunction, urinary tract infections, or diuretic use to your doctor. Pregnant or lactating individuals should seek medical guidance before use. Limit alcohol consumption while using this medication to minimize potential side effects. Regular blood glucose monitoring is essential during treatment.
Uses of Sulidapa SM 10/100/1000 Tablet ER
Managing type 2 diabetes
Major Benefits of Sulidapa SM 10/100/1000 Tablet ER:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Sulidapa SM 10/100/1000 Extended-Release tablet whole; avoid chewing, crushing, or breaking it. While this medication can be administered with or without food, consistency in timing is recommended.
Common Side effects of Sulidapa SM 10/100/1000 Tablet ER:
- Diarrhea
- Nausea
- Vomiting
- Flatulence
- Polyuria
- Dyslipidemia
- Genital fungal infection
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Urinary tract infection
- Headache
- Hypoglycemia (low blood glucose level)
- Conjunctivitis
- Cough
How to use Sulidapa SM 10/100/1000 Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for Sulidapa SM 10/100/1000 Tablet ER. Ingest the tablet whole; avoid crushing, chewing, or breaking it. While you can take it with or without food, consistent timing is recommended.
How Sulidapa SM 10/100/1000 Tablet ER works:
Sulidapa SM 10/100/1000 Extended-Release tablets contain three anti-hyperglycemic agents working synergistically. Dapagliflozin promotes increased glucose elimination via the kidneys, thus lowering blood glucose. Metformin acts by reducing both intestinal glucose absorption and hepatic glucose production. Furthermore, it enhances insulin sensitivity, improving the body's natural blood sugar regulation. Sitagliptin boosts incretin levels, stimulating pancreatic insulin secretion and suppressing excessive hepatic glucose output when blood sugar is elevated.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Sulidapa SM 10/100/1000 Tablet ER is not established as safe. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Data on the use of Sulidapa SM 10/100/1000 Extended-Release Tablets in pregnancy is absent. Seek medical advice from your physician.
Breast feedingCONSULT YOUR DOCTOR
Data on the compatibility of Sulidapa SM 10/100/1000 Tablet ER with breastfeeding is lacking. Seek medical advice.
DrivingCONSULT YOUR DOCTOR
Driving ability while using Sulidapa SM 10/100/1000 Tablet ER is undetermined. Refrain from operating a vehicle if experiencing symptoms impairing concentration or reaction time.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding Sulidapa SM 10/100/1000 Tablet ER use in individuals with renal impairment. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding Sulidapa SM 10/100/1000 Tablet ER use in individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Sulidapa SM 10/100/1000 Tablet ER :
NA
Facts to Know About Sulidapa SM 10/100/1000 Tablet ER
Label | Value |
---|---|
Potential for Dependence | None. |
Medication Classification | Medication for diabetes |